Literature DB >> 34499715

Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia.

Jenna Rossoff1, Christina Baggott2, Snehit Prabhu3, Holly Pacenta4,5, Christine L Phillips6,7, Heather Stefanski8, Julie-An Talano9, Amy Moskop9, Steven P Margossian10, Michael R Verneris11, Gary Douglas Myers12, Nicole Karras13, Patrick A Brown14, Muna Qayed15, Michelle Hermiston16, Prakash Satwani17, Christa Krupski6, Amy K Keating11, Rachel Wilcox12, Cara A Rabik14, Vanessa A Fabrizio18,19, Michael Kunicki2, Vasant Chinnabhandar8, A Yasemin Goksenin16, Kevin J Curran19,20, Crystal L Mackall21,22, Theodore W Laetsch4,23,24, Liora M Schultz25.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34499715      PMCID: PMC8617436          DOI: 10.1182/blood.2021012392

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  How I treat relapsed acute lymphoblastic leukemia in the pediatric population.

Authors:  Stephen P Hunger; Elizabeth A Raetz
Journal:  Blood       Date:  2020-10-15       Impact factor: 22.113

2.  In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.

Authors:  E Klumper; R Pieters; A J Veerman; D R Huismans; A H Loonen; K Hählen; G J Kaspers; E R van Wering; R Hartmann; G Henze
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

3.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

Review 4.  Relapsed childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Ching-Hon Pui
Journal:  Lancet Oncol       Date:  2013-05       Impact factor: 41.316

5.  Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Authors:  Marcelo C Pasquini; Zhen-Huan Hu; Kevin Curran; Theodore Laetsch; Frederick Locke; Rayne Rouce; Michael A Pulsipher; Christine L Phillips; Amy Keating; Matthew J Frigault; Dana Salzberg; Samantha Jaglowski; Joshua P Sasine; Joseph Rosenthal; Monalisa Ghosh; Daniel Landsburg; Steven Margossian; Paul L Martin; Manali K Kamdar; Peiman Hematti; Sarah Nikiforow; Cameron Turtle; Miguel-Angel Perales; Patricia Steinert; Mary M Horowitz; Amy Moskop; Lida Pacaud; Lan Yi; Raghav Chawla; Eric Bleickardt; Stephan Grupp
Journal:  Blood Adv       Date:  2020-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.